Equities

Genky DrugStores Co Ltd

9267:TYO

Genky DrugStores Co Ltd

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (JPY)3,070.00
  • Today's Change35.00 / 1.15%
  • Shares traded26.70k
  • 1 Year change+20.87%
  • Beta0.6390
Data delayed at least 20 minutes, as of Nov 15 2024 03:46 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in JPYIncome statement in JPYView more

Year on year Genky DrugStores Co Ltd grew revenues 9.35% from 169.06bn to 184.86bn while net income improved 32.74% from 4.77bn to 6.33bn.
Gross margin20.41%
Net profit margin3.44%
Operating margin4.69%
Return on assets5.76%
Return on equity14.36%
Return on investment8.65%
More ▼

Cash flow in JPYView more

In 2024, Genky DrugStores Co Ltd increased its cash reserves by 10.64%, or 567.00m. The company earned 13.26bn from its operations for a Cash Flow Margin of 7.17%. In addition the company used 10.63bn on investing activities and also paid 2.06bn in financing cash flows.
Cash flow per share399.87
Price/Cash flow per share7.82
Book value per share1,582.20
Tangible book value per share1,570.32
More ▼

Balance sheet in JPYView more

Genky DrugStores Co Ltd has a Debt to Total Capital ratio of 41.95%, a lower figure than the previous year's 58.54%.
Current ratio1.03
Quick ratio0.4102
Total debt/total equity0.7228
Total debt/total capital0.4195
More ▼

Growth rates in JPY

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 2.00% and 32.63%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Retail (Drugs) industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg)0.63%
Div growth rate (5 year)0.40%
Payout ratio (TTM)5.97%
EPS growth(5 years)18.94
EPS (TTM) vs
TTM 1 year ago
26.47
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.